Bristol Myers strengthens its Opdivo franchise with rising demand and strong uptake of Qvantig, leveraging label expansions to sustain revenue growth.

Bristol Myers' strong Q3 growth portfolio, led by Opdivo and Reblozyl, helped counter declines in legacy drug sales.

Bristol Myers' strong Q3 growth portfolio, led by Opdivo and Reblozyl, helped counter declines in legacy drug sales.

SE Limited's DFS unit posts 60% revenue growth as its loan book nears $8B, fueled by strong demand, rising adoption and broader product expansion.

SE Limited's DFS unit posts 60% revenue growth as its loan book nears $8B, fueled by strong demand, rising adoption and broader product expansion.

Arista Networks posts strong revenue growth fueled by AI networking leadership and rising demand for its Etherlink portfolio, boosting momentum.

ABBV's neuroscience drugs drive strong Q3 momentum, with rising Botox Therapeutic sales, migraine therapies and new PD treatments fueling growth.

IBM links its AI platform with Microsoft Copilot to boost consulting efficiency, streamline workflows and tap rising AI services demand.

IBM links its AI platform with Microsoft Copilot to boost consulting efficiency, streamline workflows and tap rising AI services demand.

T expands its small-business portfolio with 5G, fiber and new tools, aiming to tap rising demand for faster, more reliable connectivity.